Universal Scientific Current Valuation vs. Return On Asset
| 601231 Stock | 15.50 0.21 1.37% |
For Universal Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Universal Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Universal Scientific Industrial utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Universal Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Universal Scientific Industrial over time as well as its relative position and ranking within its peers.
Universal |
Universal Scientific Return On Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Universal Scientific's current stock value. Our valuation model uses many indicators to compare Universal Scientific value to that of its competitors to determine the firm's financial worth. Universal Scientific Industrial is the top company in current valuation category among its peers. It also is number one stock in return on asset category among its peers . The ratio of Current Valuation to Return On Asset for Universal Scientific Industrial is about 1,064,430,547,911 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Universal Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Universal Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Universal Current Valuation vs. Competition
Universal Scientific Industrial is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Information Technology industry is presently estimated at about 10.86 Trillion. Universal Scientific adds roughly 31.08 Billion in current valuation claiming only tiny portion of equities under Information Technology industry.
Universal Return On Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Universal Scientific |
| = | 31.08 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Universal Scientific |
| = | 0.0292 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Universal Return On Asset Comparison
Universal Scientific is currently under evaluation in return on asset category among its peers.
Universal Scientific Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Universal Scientific, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Universal Scientific will eventually generate negative long term returns. The profitability progress is the general direction of Universal Scientific's change in net profit over the period of time. It can combine multiple indicators of Universal Scientific, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 2.5 B | 1.3 B | |
| Income Before Tax | 2.2 B | 1.4 B | |
| Net Income Applicable To Common Shares | 3.5 B | 3.7 B | |
| Net Income | 1.9 B | 1.2 B | |
| Income Tax Expense | 479.8 M | 503.8 M | |
| Net Income From Continuing Ops | 1.9 B | 1.7 B | |
| Total Other Income Expense Net | 206.6 M | 128.6 M | |
| Net Interest Income | -180 M | -171 M | |
| Interest Income | 236.5 M | 248.4 M | |
| Change To Netincome | 156.4 M | 164.2 M |
Universal Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Universal Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Universal Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Universal Scientific's important profitability drivers and their relationship over time.
Use Universal Scientific in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Universal Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Scientific will appreciate offsetting losses from the drop in the long position's value.Universal Scientific Pair Trading
Universal Scientific Industrial Pair Trading Analysis
The ability to find closely correlated positions to Universal Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Universal Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Universal Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Universal Scientific Industrial to buy it.
The correlation of Universal Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Universal Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Universal Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Universal Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Universal Scientific position
In addition to having Universal Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Junk Bonds Funds Thematic Idea Now
Junk Bonds Funds
Funds or Etfs that invest most of their assets into speculative (junk) bonds or to other fixed income instruments with interest rates 3 to 4 percentage points above government issues. The Junk Bonds Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Junk Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Universal Stock
To fully project Universal Scientific's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Universal Scientific's income statement, its balance sheet, and the statement of cash flows.